From: Experience with periprosthetic infection after limb salvage surgery for patients with osteosarcoma
Characteristics | Information |
---|---|
Age, years | 20.0 ± 8.4 |
Gender, N (%) | |
Male | 37 (69.8) |
Female | 16 (30.2) |
Tumor site, N (%) | |
P. Femur | 2 (3.8) |
D. Femur | 27 (50.9) |
P. Tibia | 24 (45.3) |
Initial surgery | |
Blood loss, mean ± sd (range) mL | 497.8 ± 477.5 (100–2800) |
Operation time, mean ± sd (range) hours | 4.8 ± 2.03 (1.5–12) |
Time to infection post-op, mean ± sd (range) months | 20.1 ± 29.3 (1–121) |
Interval between spacer insertion and second revision, mean ± sd (range) months | 6.9 ± 5.3 (4–18) |
Pre- and post-operation chemotherapy, N (%) | 53 (100) |
Infectious manifestation, N (%) | |
Fever | 15 (28.3) |
Localized redness, swelling, heat and pain | 28 (52.8) |
Malodorous drainage | 26 (49.1) |
Germiculture, N (%) | |
Staphylococcus aureus | 5 (9.4) |
Staphylococcus epidermidis | 3 (5.7) |
Escherichia coli | 1 (1.9) |
Stenotrophomonas maltophilia | 1 (1.9) |
Pseudomonas aeruginosa | 1 (1.9) |
None | 38 (79.2) |